- call +1-201-465-4211
- email sales@mrinsights.biz
Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the border of a scar and develop into a lump. The cause of keloid development cannot be determined but it can develop after surgery, burn injury, piercing, trauma, acne, vaccination and other wounds or cuts. According to the National Institute of Health, keloid scars are commonly seen in people in the age group 10 to 30 years of age.
Scope of the Report:
This report focuses on the Keloid Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Excision treatment type segment is anticipated to reach a market value of US$ 1,172.1 Mn by 2025 end, expanding at a CAGR of 3.4% during the forecast period.
The worldwide market for Keloid Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
Sensus
RXi
Sonoma
Perrigo
Bristol-Myers Squibb
Pacific World
Valeant
Revitol
Avita
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others
Market Segment by Applications, can be divided into
Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others
There are 15 Chapters to deeply display the global Keloid Treatment market.
Chapter 1, to describe Keloid Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Keloid Treatment, with sales, revenue, and price of Keloid Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Keloid Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Keloid Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Keloid Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Keloid Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Occlusive Dressing
1.2.2 Compression Therapy
1.2.3 Cryosurgery
1.2.4 Excision
1.2.5 Radiation Therapy
1.2.6 Laser Therapy
1.2.7 Interferon Therapy
1.2.8 Intralesional Corticosteroid Injection
1.2.9 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Dermatology Clinics
1.3.3 Ambulatory Surgical Centres
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Keloid Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sensus
2.2.1 Business Overview
2.2.2 Keloid Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sensus Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 RXi
2.3.1 Business Overview
2.3.2 Keloid Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 RXi Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sonoma
2.4.1 Business Overview
2.4.2 Keloid Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sonoma Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Perrigo
2.5.1 Business Overview
2.5.2 Keloid Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Perrigo Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Keloid Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pacific World
2.7.1 Business Overview
2.7.2 Keloid Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pacific World Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant
2.8.1 Business Overview
2.8.2 Keloid Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Revitol
2.9.1 Business Overview
2.9.2 Keloid Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Revitol Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Avita
2.10.1 Business Overview
2.10.2 Keloid Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Avita Keloid Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Keloid Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Keloid Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Keloid Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Keloid Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Keloid Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Keloid Treatment Market Analysis by Regions
4.1 Global Keloid Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Keloid Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Keloid Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Keloid Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Keloid Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Keloid Treatment Sales and Growth Rate (2013-2018)
4.5 South America Keloid Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Keloid Treatment Sales and Growth Rate (2013-2018)
5 North America Keloid Treatment by Countries
5.1 North America Keloid Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Keloid Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Keloid Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Keloid Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Keloid Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Keloid Treatment Sales and Growth Rate (2013-2018)
6 Europe Keloid Treatment by Countries
6.1 Europe Keloid Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Keloid Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Keloid Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Keloid Treatment Sales and Growth Rate (2013-2018)
6.3 UK Keloid Treatment Sales and Growth Rate (2013-2018)
6.4 France Keloid Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Keloid Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Keloid Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Keloid Treatment by Countries
7.1 Asia-Pacific Keloid Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Keloid Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Keloid Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Keloid Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Keloid Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Keloid Treatment Sales and Growth Rate (2013-2018)
7.5 India Keloid Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Keloid Treatment Sales and Growth Rate (2013-2018)
8 South America Keloid Treatment by Countries
8.1 South America Keloid Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Keloid Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Keloid Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Keloid Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Keloid Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Keloid Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Keloid Treatment by Countries
9.1 Middle East and Africa Keloid Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Keloid Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Keloid Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Keloid Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Keloid Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Keloid Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Keloid Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Keloid Treatment Sales and Growth Rate (2013-2018)
10 Global Keloid Treatment Market Segment by Type
10.1 Global Keloid Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Keloid Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Keloid Treatment Revenue and Market Share by Type (2013-2018)
10.2 Occlusive Dressing Sales Growth and Price
10.2.1 Global Occlusive Dressing Sales Growth (2013-2018)
10.2.2 Global Occlusive Dressing Price (2013-2018)
10.3 Compression Therapy Sales Growth and Price
10.3.1 Global Compression Therapy Sales Growth (2013-2018)
10.3.2 Global Compression Therapy Price (2013-2018)
10.4 Cryosurgery Sales Growth and Price
10.4.1 Global Cryosurgery Sales Growth (2013-2018)
10.4.2 Global Cryosurgery Price (2013-2018)
10.5 Excision Sales Growth and Price
10.5.1 Global Excision Sales Growth (2013-2018)
10.5.2 Global Excision Price (2013-2018)
10.6 Radiation Therapy Sales Growth and Price
10.6.1 Global Radiation Therapy Sales Growth (2013-2018)
10.6.2 Global Radiation Therapy Price (2013-2018)
10.7 Laser Therapy Sales Growth and Price
10.7.1 Global Laser Therapy Sales Growth (2013-2018)
10.7.2 Global Laser Therapy Price (2013-2018)
10.8 Interferon Therapy Sales Growth and Price
10.8.1 Global Interferon Therapy Sales Growth (2013-2018)
10.8.2 Global Interferon Therapy Price (2013-2018)
10.9 Intralesional Corticosteroid Injection Sales Growth and Price
10.9.1 Global Intralesional Corticosteroid Injection Sales Growth (2013-2018)
10.9.2 Global Intralesional Corticosteroid Injection Price (2013-2018)
10.10 Others Sales Growth and Price
10.10.1 Global Others Sales Growth (2013-2018)
10.10.2 Global Others Price (2013-2018)
11 Global Keloid Treatment Market Segment by Application
11.1 Global Keloid Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Dermatology Clinics Sales Growth (2013-2018)
11.4 Ambulatory Surgical Centres Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Keloid Treatment Market Forecast (2018-2023)
12.1 Global Keloid Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Keloid Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Keloid Treatment Market Forecast (2018-2023)
12.2.2 Europe Keloid Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Keloid Treatment Market Forecast (2018-2023)
12.2.4 South America Keloid Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Keloid Treatment Market Forecast (2018-2023)
12.3 Keloid Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Keloid Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Keloid Treatment Market Share Forecast by Type (2018-2023)
12.4 Keloid Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Keloid Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Keloid Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Keloid Treatment Picture
Table Product Specifications of Keloid Treatment
Figure Global Sales Market Share of Keloid Treatment by Types in 2017
Table Ke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
